A Study to Assess Efficacy and Safety of RESP301 Plus Standard of Care (SOC) Compared to SOC Alone in Hospitalized Participants With COVID-19
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Clinical Trials Related to COVID-19
Related studies linked through entity extraction aliases.
COVID-19 Follow up Intensive Care Studies
- Status
- COMPLETED
- Phase
- N/A
Respiratory Physiotherapy in Severe COVID-19 Patients
- Status
- COMPLETED
- Phase
- N/A
A Study of Combination Therapies to Treat COVID-19 Infection
- Status
- WITHDRAWN
- Phase
- PHASE2
Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia
- Status
- UNKNOWN
- Phase
- PHASE2
COVID-19 Surveillance Based on Smart Wearable Device
- Status
- COMPLETED
- Phase
- N/A
Effect of Availability of COVID-19 Testing on Choice to Isolate and Socially Distance
- Status
- COMPLETED
- Phase
- NA
PHenotyping patiENts Admitted to Hospital With cOvid-19 Infection and idenTifYing Prognostic markErs
- Status
- UNKNOWN
- Phase
- N/A
Tigerase® Efficacy and Safety as Part of Complex Therapy in Patients With COVID-19
- Status
- COMPLETED
- Phase
- PHASE3
The Nitazoxanide Plus Atazanavir for COVID-19 Study
- Status
- TERMINATED
- Phase
- PHASE2
Non-comparative Trial of the Combination of HCQ and AZI in the Treatment of ICU Patients
- Status
- TERMINATED
- Phase
- PHASE2
SURgical Outcomes in COvid Patients - the SUROCO Multicenter Cohort Study (COVID-19)
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients
- Status
- TERMINATED
- Phase
- PHASE2
Part Two of Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals
- Status
- COMPLETED
- Phase
- PHASE3
Study of Ampion for the Treatment of Adult COVID-19 Patients Requiring Oxygen Supplementation
- Status
- COMPLETED
- Phase
- PHASE1
Convalescent Plasma as Treatment for Subjects With Early COVID-19 Infection
- Status
- TERMINATED
- Phase
- PHASE2
Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Atovaquone for Treatment of COVID-19
- Status
- COMPLETED
- Phase
- PHASE2
Study on the Recovery of Pulmonary Function, Chest CT, Airway Microbiota, Hematologic, and Immune & Inflammatory Conditions in COVID-19 Rehabilitation Patients
- Status
- UNKNOWN
- Phase
- N/A